Efficacy of 25 (OH) Vitamin D Supplementation and Physical Activity in Improving Musculoskeletal Health in Individuals with Chronic Kidney Disease (CKD). A Multicenter Randomized, Controlled Trial

Sunday, 17 August 2014
Exhibit hall (Dena'ina Center)
Bilal Ahmed, MS , The Aga khan University, Karachi, Pakistan
Waqar Kashif, MD , The Aga Khan University, Karachi, Pakistan
Romaina Iqbal, PhD , The Aga Khan university, Karachi, Pakistan
Aysha Habib, MD , The Aga khan university, Karachi, Pakistan
Kiran Nasir, MD , Kidney Center, Karachi, Pakistan
INTRODUCTION:  

We investigated the role of vitamin D (VD) and targeted physical activity in improving musculoskeletal health among chronic kidney diseases (CKD) patients. 

METHODS:  

An open-label, randomized controlled trial of VD replacement in stage 2-4 CKD patients, attending two nephrology clinics of Karachi, Pakistan was undertaken. 2637 subjects were contacted, 115 found to be deficient for 25 hydroxy vitamin D (25 OHD) levels were block randomized to either  4000 IU of daily oral vitamin D3 (cholecalciferol)  or combination of daily drops along with targeted physical therapy for three months. A predesigned questionnaire along with IPAQ was administered to assess the physical activity. Baseline biochemical testing for calcium, Phosphate, bone alkaline phosphatse, iPTH were performed. Musculoskeletal health was assessed by trained physical therapist by measuring bicep strength, back flexibility and fat composition and hand grip assessment. The outcome was improvement in musculoskeletal health to be assessed by plasma iPTH, calcium, bone specific alkaline phosphatase and hand grip strength assessment and improvement in serum 25OHD levels. Analysis was by intention to treat.

RESULTS:  

Of the 115 VD deficient subjects enrolled at baseline, 42 were lost to follow-up (47% in vitamin D alone versus 52% in vitamin along with physical activity group). The mean 25OHD level at the baseline was comparable in both the arms. At follow-up, 25OHD  status was 85.0 ± 8.9 nmol/liter in the VD group and 95.8 ± 6.6 nmol/liter in VD along with physical activity group. There was significant improvement in the musculoskeletal health in the second arm compared to VD alone as well as within the group improvement (p value ≤ 0.03).

CONCLUSIONS:  Treatment with both VD and targeted physical activity was found to be effective for improving musculoskeletal health (strength, muscle force, or power) in CKD patients.